Document is current

Article History

Received: 3 February 2023

Accepted: 12 December 2023

First Online: 19 December 2023

Declarations

:

: Byong Duk Ye has received consulting fees from AbbVie Korea, BMS Pharmaceutical Korea Ltd., Celltrion, Chong Kun Dang Pharm, CJ Red BIO, Curacle, Daewoong Pharma., Ferring Korea, IQVIA, Janssen Korea, Kangstem Biotech, Korea Otsuka Pharm., Korea United Pharm. Inc., Medtronic Korea, NanoEntek, ORGANOIDSCIENCES LTD., Pfizer Korea, Takeda, Takeda Korea; speaker fees from AbbVie Korea, Celltrion, Cornerstones Health, Curacle, Ferring Korea, Janssen Korea, Pfizer Korea, Takeda Korea, IQVIA; and research support from Celltrion and Pfizer Korea. Seonjeong Jeong is a former AbbVie employee. AbbVie sponsored the study; contributed to the design; participated in the collection, analysis, and interpretation of data; in writing, reviewing, and approval of the final version. No honoraria or payments were made for authorship. Otherwise, there are no authors and companies with conflict of interest in relation to the contents of the presentation.

: This study was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki, and was approved by the Institutional Review Board of each participating hospital [Yonsei University Health System Institutional Review Board (4-2015-1112); Ajou University Hospital Institutional Review Board (AJIRB-MED-OBS-15-458); The Catholic University of Korea St. Vincent’s Hospital Institutional Review Board (VC17OODE0085); Pusan National University Yangsan Hospital Institutional Review Board (02-2017-009); Seoul St. Mary’s Hospital, The Catholic University of Korea Institutional Review Board (KC15OSME0868); Asan Medical center Institutional review board (2016 − 0139); Kosin University Gospel Hospital Institutional Review Board (KUGH 2017-03-013); KyungPook National University Hospital Institutional Review Board (2015-12-010-001); Institutional review board, Clinical Research Institute, Seoul National University Hospital (H-1512-034-726); Samsung Medical Center Institutional Review Board (2015-11-133)]. All patients agreed to the conditions of the study and signed their informed consents.

: Not applicable.